Axon Enterprise, Inc $AXON Shares Bought by Handelsbanken Fonder AB

Handelsbanken Fonder AB grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 6.5% during the second quarter, HoldingsChannel reports. The firm owned 69,798 shares of the biotechnology company’s stock after acquiring an additional 4,261 shares during the period. Handelsbanken Fonder AB’s holdings in Axon Enterprise were worth $39,129,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of AXON. Evergreen Capital Management LLC grew its position in shares of Axon Enterprise by 3.8% in the second quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after purchasing an additional 15 shares in the last quarter. Synergy Financial Group LTD increased its holdings in shares of Axon Enterprise by 1.4% in the third quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company’s stock valued at $996,000 after purchasing an additional 19 shares during the last quarter. Tower Research Capital LLC TRC lifted its position in Axon Enterprise by 1.2% during the second quarter. Tower Research Capital LLC TRC now owns 1,631 shares of the biotechnology company’s stock worth $1,350,000 after buying an additional 19 shares in the last quarter. Certuity LLC lifted its position in Axon Enterprise by 5.1% during the fourth quarter. Certuity LLC now owns 474 shares of the biotechnology company’s stock worth $269,000 after buying an additional 23 shares in the last quarter. Finally, Pure Financial Advisors LLC lifted its position in Axon Enterprise by 6.7% during the fourth quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock worth $207,000 after buying an additional 23 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Earnings beat supports the rally: Axon reported quarterly earnings of $1.88 per share versus the $1.84 consensus estimate, while revenue of $904.4 million exceeded expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the company’s strong demand across connected public-safety hardware and software. Axon Jumps After Earnings Beat and Analyst Target Hikes
• Positive Sentiment: Analyst support and future catalysts: Analyst target increases and the post-earnings rebound have improved sentiment, with investors awaiting the next potential growth catalyst. The company’s expanding product ecosystem and strong top-line growth remain central to the bullish case. Analyst Target Hikes and Next Catalyst
• Neutral Sentiment: Short-interest data provides no signal: Reported short interest was zero shares, with a zero-day days-to-cover ratio. Because the figures show no meaningful short position, they are unlikely to explain the stock’s move or provide useful evidence of future buying pressure.
• Negative Sentiment: Valuation remains demanding: Commentary highlights Axon’s strong growth but also its high valuation, while another analyst downgraded the stock and suggested taking some profits. The shares trade at a very high earnings multiple, leaving them vulnerable if growth or profitability disappoints. Axon Rating Downgrade
• Negative Sentiment: Margin pressure and insider selling temper enthusiasm: Investors remain focused on memory costs and counter-drone hardware expenses, which may constrain margins as Axon invests for growth. CEO Patrick W. Smith also sold approximately $5.5 million of shares under a pre-arranged Rule 10b5-1 plan, though the sale represented only about 0.33% of his holdings.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on AXON shares. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Thursday, August 6th. Morgan Stanley lifted their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. UBS Group boosted their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research report on Thursday, August 6th. Finally, Piper Sandler upped their price objective on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $730.92.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 20,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the completion of the sale, the chief executive officer directly owned 3,060,997 shares of the company’s stock, valued at approximately $1,530,498,500. This trade represents a 0.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares in the company, valued at approximately $16,501,640. This trade represents a 4.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Up 6.7%

AXON stock opened at $636.31 on Wednesday. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $824.66. The firm has a market cap of $51.69 billion, a PE ratio of 264.03, a PEG ratio of 12.17 and a beta of 1.39. The firm’s 50 day moving average price is $519.11 and its 200-day moving average price is $473.46. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm’s revenue for the quarter was up 35.3% compared to the same quarter last year. During the same period in the prior year, the business posted $2.12 earnings per share. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.